Two Key Cannabis Trends Surged - Entourage Health's Financial Results Show Why
Portfolio Pulse from Jelena Martinovic
Entourage Health Corp. reported Q2 2023 financial results, with total revenue of CA$13.37 million ($9.83 million) and net revenue of CA$10.17 million, representing a total revenue increase of 1% and a net revenue increase of 5% YoY. The increase in total revenue is attributed to an 8% increase in adult-use revenue and a 45% increase in pre-roll revenue YoY. The company also introduced new product lines and expanded its pre-roll series. However, the company's gross profit and cash equivalents decreased, while its loss remained steady.
August 30, 2023 | 1:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Entourage Health's Q2 2023 results show steady growth in revenue, driven by increased adult-use and pre-roll sales. However, the company's gross profit and cash equivalents decreased, while its loss remained steady.
Entourage Health's Q2 2023 results show a steady increase in revenue, which is a positive sign. However, the decrease in gross profit and cash equivalents, along with a steady loss, could be concerning for investors. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100